Results 131 to 140 of about 3,398 (179)

Comparative Impact of Intravenous Iron Sucrose and Ferric Carboxymaltose on Hypophosphatemia and Anemia Parameters in Iron Deficiency Anemia: A Retrospective Study. [PDF]

Ther Clin Risk Manag
Aslan S, Doğan S, Sarıaydın M, Vural A, Kuloglu E, Muhtaroğlu A.   +5 more
europepmc   +1 more source

A Randomized, Open-Label, Single-Dose, Parallel-Group Bioequivalence Study of Ferric Carboxymaltose Injection Under Fasting Conditions in Chinese Adult Subjects With Iron Deficiency Anemia. [PDF]

Pharmacol Res Perspect
Gong F, Hu S, Yuan J, Song J.
europepmc   +1 more source

Intravenous administration of ferric derisomaltose is associated with a higher incidence of infusion reactions than ferric carboxymaltose, and unaffected by dilution volume. [PDF]

Intern Med J
Lucas S, Chauhan A, Hurley C, Xu C, Yu C, Tan K, Taylor S, Suleiman M, Leung T, Garg M.   +9 more
europepmc   +1 more source

Ferric carboxymaltose for anemia in late pregnancy: a randomized controlled trial. [PDF]

Nat Med
Pasricha SR, Moya E, Ataíde R, Mzembe G, Harding R, Mwangi MN, Zinenani T, Prang KH, Kaunda J, Mtambo OPL, Vokhiwa M, Mhango G, Mamani-Mategula E, Fielding K, Demir A, Von Dinklage N, Verhoef H, McLean AR, Manda-Taylor L, Braat S, Phiri KS.   +20 more
europepmc   +1 more source

Treatment-Resistant Hypophosphataemia After Ferric Carboxymaltose: Expanding the Spectrum of 6h Syndrome (Hypophosphataemia, Hyperphosphaturia, Hypovitaminosis D, Hypocalcaemia, Secondary Hyperparathyroidism, High Fibroblast Growth Factor-23). [PDF]

Eur J Case Rep Intern Med
Rashid L.
europepmc   +1 more source

Author Correction: Ferric carboxymaltose for anemia in late pregnancy: a randomized controlled trial. [PDF]

Nat Med
Pasricha SR, Moya E, Ataíde R, Mzembe G, Harding R, Mwangi MN, Zinenani T, Prang KH, Kaunda J, Mtambo OPL, Vokhiwa M, Mhango G, Mamani-Mategula E, Fielding K, Demir A, Von Dinklage N, Verhoef H, McLean AR, Manda-Taylor L, Braat S, Phiri KS.   +20 more
europepmc   +1 more source

Intravenous Ferric Carboxymaltose in Heart Failure With Iron Deficiency: The FAIR-HF2 DZHK05 Randomized Clinical Trial.

JAMA
Anker SD, Friede T, Butler J, Talha KM, Placzek M, Diek M, Nosko A, Stas A, Kluge S, Jarczak D, deHeer G, Rybczynski M, Bayés-Genís A, Böhm M, Coats AJS, Edelmann F, Filippatos G, Hasenfuß G, Haverkamp W, Lainscak M, Landmesser U, Macdougall IC, Merkely B, Pieske BM, Pinto FJ, Rassaf T, Visser-Rogers JK, Rosano G, Volterrani M, von Haehling S, Anker MS, Doehner W, Ince H, Koehler F, Savarese G, Khan MS, Rauch-Kröhnert U, Gori T, Trenkwalder T, Akin I, Paitazoglou C, Kobielusz-Gembala I, Kuthi L, Frey N, Licka M, Kääb S, Laugwitz KL, Ponikowski P, Karakas M.   +48 more
europepmc   +1 more source

Ferric carboxymaltose in reducing blood transfusions and infections after cardiac surgery. [PDF]

JTCVS Open
Kiviniemi TO, Anttila V, Pälve K, Vesanen M, Lehto J, Malmberg M, Vasankari T, Airaksinen KEJ, Gunn J.   +8 more
europepmc   +1 more source

Patient with Secondary Amyloidosis Due to Crohn's Disease on Hemodialysis Effectively Treated with Ferric Carboxymaltose Injections: A Case Report and Literature Review. [PDF]

Diseases
Ueno M, Hirai F, Fuji A, Shimomura Y, Uemoto K, Masutani K, Saito T.   +6 more
europepmc   +1 more source

Safety and Efficacy of Ferric Carboxymaltose for Iron Deficiency Anemia in Inflammatory Bowel Disease: A Systematic Review. [PDF]

Cureus
Malireddi A, Abera M, Suresh SB, Ansar M, Boddeti S, Noor K, Khan S.   +6 more
europepmc   +1 more source